New Hyaluronic Acid‐Based Bioengineered 3D Scaffold: Fabrication and Potential for Oocyte In Vitro Maturation
Biotechnology and Bioengineering · 2026
DOI: 10.1002/bit.70257 ↗At a glance
Journal article in Biotechnology and Bioengineering, 2026. Written by Ludovica Cacopardo and 4 co-authors. Institution: Research Centre E. Piaggio, University of Pisa, Pisa, Italy. Major MEDLINE topics: Hyaluronic Acid, Tissue Scaffolds, Oocytes, In Vitro Oocyte Maturation Techniques. 75 references. The full text is freely available in PubMed Central. Funded by: Bando ERC Seeds Uniba cod prog, European Union Next-Generation EU-Italian PRIN, Italian Ministry for Education.
Abstract (original language)
Oocyte in vitro maturation (IVM) is a valuable tool in human and animal reproduction, but its efficiency remains lower than that obtainable in vivo, partly due to suboptimal used culture conditions. This study aimed to evaluate the effects of adding hyaluronic acid (HA) to spherical alginate‐based 3D scaffolds to better mimic the native ovarian intrafollicular microenvironment. HA (2 or 4 mg/mL) was incorporated into an alginate/collagen I/granulosa cell matrix to fabricate bioengineered microbeads, which were characterized for morphology, microstructure and mechanical properties. Sheep cumulus‐oocyte complexes were encapsulated and cultured for 24 h in such microbeads for IVM and subsequent IVEC. HA‐enriched scaffolds displayed sphericity, stability, concentration‐dependent reduction in pore size and slight increase in stiffness. In scaffolds with 2 mg/mL HA, cumulus cell expansion, metaphase II and embryo cleavage rates were significantly improved compared to controls, scaffolds without HA and 4 mg/mL HA. Apoptosis levels in cumulus and granulosa cells were significantly lower with 2 mg/mL HA. SEM imaging suggested cell‐driven extracellular matrix (ECM) remodelling during IVM. These results indicate that 2 mg/mL HA provides the optimal balance between structural support and mechanical compliance, promoting oocyte maturation. Further studies are needed to elucidate the underlying molecular mechanisms.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Research Centre E. Piaggio, University of Pisa, Pisa, Italy.
- Department of Information Engineering, University of Pisa, Pisa, Italy.
- Department of Biosciences, Biotechnology and Environment, University of Bari Aldo Moro, Bari, Italy.
ORCID profiles: Ludovica Cacopardo, Antonella Mastrorocco
Funding
- Bando ERC Seeds Uniba cod prog
- European Union Next-Generation EU-Italian PRIN
- Italian Ministry for Education
- Unione europea - FSE-REACT-EU, PON Ricerca e Innovazione
- Italian Ministry of Education and Research (MUR)
Cite
APA
Cacopardo, L., Martino, N. A., Michele, F., Fontana, F., & Mastrorocco, A. (2026). New Hyaluronic Acid‐Based Bioengineered 3D Scaffold: Fabrication and Potential for Oocyte In Vitro Maturation. Biotechnology and Bioengineering. https://doi.org/10.1002/bit.70257
Vancouver
Cacopardo L, Martino NA, Michele F, Fontana F, Mastrorocco A. New Hyaluronic Acid‐Based Bioengineered 3D Scaffold: Fabrication and Potential for Oocyte In Vitro Maturation. Biotechnology and Bioengineering. 2026. doi:10.1002/bit.70257
BibTeX
@article{Cacopardo2026,
author = {Cacopardo, Ludovica and Martino, Nicola Antonio and Michele, Francesca De and Fontana, Francesco and Mastrorocco, Antonella},
title = {New Hyaluronic Acid‐Based Bioengineered 3D Scaffold: Fabrication and Potential for Oocyte In Vitro Maturation},
journal = {Biotechnology and Bioengineering},
year = {2026},
doi = {10.1002/bit.70257}
}
EUVIMED